Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Sell
34,972
-6,508
-16% -$1.29M 0.41% 47
2026
Q1
$6.11M Buy
41,480
+2,360
+6% +$345K 0.27% 61
2025
Q4
$4.75M Buy
39,120
+130
+0.3% +$15.2K 0.21% 73
2025
Q3
$4.21M Buy
38,990
+4,280
+12% +$399K 0.19% 77
2025
Q2
$3.11M Sell
34,710
-2,910
-8% -$219K 0.15% 98
2025
Q1
$2.56M Buy
37,620
+320
+0.9% +$23.1K 0.13% 114
2024
Q4
$2.35M Buy
37,300
+12,840
+52% +$868K 0.12% 125
2024
Q3
$1.89M Buy
24,460
+4,760
+24% +$373K 0.1% 136
2024
Q2
$1.62M Buy
19,700
+11,560
+142% +$854K 0.09% 139
2024
Q1
$569K Buy
+8,140
New +$523K 0.03% 184
2018
Q4
Sell
-170
Closed -$2K 371
2018
Q3
$2K Hold
170
﹤0.01% 503
2018
Q2
$2K Buy
170
+50
+42% +$544 ﹤0.01% 467
2018
Q1
$1K Buy
+120
New +$1.33K ﹤0.01% 443

Other funds holding KLAC

Trilogy Capital's KLAC Position: Q2 2026 in Review

Trilogy Capital reduced its KLA (KLAC) stake by 16% in Q2 2026, selling an estimated $1.29M and leaving 34,972 shares worth $10.6M. The position accounts for 0.41% of the portfolio, ranked #47.

Trilogy Capital first reported a position in KLAC in Q1 2018 and has held it in 13 quarters since. 414 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Trilogy Capital held 34,972 shares of KLA worth $10.6M as of Q2 2026.
  • Trilogy Capital sold 6,508 KLA shares in Q2 2026, an estimated $1.29M.
  • KLA made up 0.41% of Trilogy Capital's portfolio in Q2 2026, its #47 holding.
  • Trilogy Capital first reported a position in KLA in Q1 2018 and has held it in 13 quarters since.
  • 414 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.